Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 115Brain Neoplasms 114Prostatic Neoplasms 101Neoplasm Metastasis 79Carcinoma, Hepatocellular 69Lung Neoplasms 67Pancreatic Neoplasms 64Breast Neoplasms 48Melanoma 37Carcinoma, Renal Cell 33Neoplasms 31Squamous Cell Carcinoma of Head and Neck 21Colorectal Neoplasms 20Liver Neoplasms 19Glioblastoma 18Small Cell Lung Carcinoma 14Head and Neck Neoplasms 14Sarcoma 11Kidney Neoplasms 11Glioma 10Recurrence 8Urinary Bladder Neoplasms 7Radiation Injuries 6Neuroma, Acoustic 6Cholangiocarcinoma 6Adenocarcinoma 6Uveal Melanoma 5Uterine Cervical Neoplasms 5Prostate Cancer Metastatic 5Ovarian Neoplasms 5

Interventions

apatinib 2Erlotinib Hydrochloride 2Carboplatin 2sintilimab 1durvalumab 1camrelizumab 1Vinorelbine 1Tyrosine Kinase Inhibitors 1Telescopes 1Radiotherapy 1Radiosurgery 1Pemetrexed 1Gemcitabine 1Gefitinib 1Etoposide 1Docetaxel 1Dasatinib 1Cisplatin 1Afatinib 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Respiratory Tract Diseases × Radiosurgery × Clear all
NCT02904954 2023-10-11

Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer

Weill Medical College of Cornell University

Phase 2 Completed
60 enrolled 12 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡